Patent Assignment
Reel/Frame 053685/0346
Assignment of Assignor's Interest
Recorded: 2020-09-03
Pages: 3
Assignor
TRANSLATE BIO MA, INC.
Executed: 2018-01-23
Assignee
TRANSLATE BIO, INC.
29 HARTWELL AVENUE, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Messenger RNA Therapy for the Treatment of Ornithine Transcarbamylase Deficiency
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 2, 2017
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: RANA THERAPEUTICS, INC.
Reel/Frame 044353/0922 →
Change of Name
Nov 2, 2017
From: RANA THERAPEUTICS, INC.
To: TRANSLATE BIO, INC.
Reel/Frame 044354/0009 →
Assignment of Assignor's Interest
Nov 2, 2017
From: HEARTLEIN, MICHAEL; DEROSA, FRANK; SMITH, LIANNE
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 044019/0252 →
Assignment of Assignor's Interest
Jan 25, 2018
From: DEROSA, FRANK; HEARTLEIN, MICHAEL; SMITH, LIANNE; KARVE, SHRIRANG
To: TRANSLATE BIO MA, INC.
Reel/Frame 044732/0044 →